PCDH19 and cholesteryl ester measurement: These findings indicate that PCDH19 mutations disrupt normal neuronal development and excitability, and that Ngn2 hiPSC-derived mosaic neurons provide a powerful in vitro model for studying disease mechanisms and testing targeted therapies for PCDH19-CE.